Moedas / LXRX
LXRX: Lexicon Pharmaceuticals Inc
1.10
USD
0.05
(4.35%)
A taxa do LXRX para hoje mudou para -4.35%. Paralelamente, o preço mais baixo no mercado atingiu 1.09 e o mais alto foi 1.15.
Veja a dinâmica do par de moedas Lexicon Pharmaceuticals Inc. As cotações em tempo real ajudam a reagir rapidamente aos movimentos do mercado. Ao alternar entre os diferentes períodos de tempo, você pode monitorar tendências e movimentos de preços por minuto, hora, dia, semana ou mês. Use estas informações para prever os movimentos do mercado e tomar decisões de negociação informadas.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
LXRX Notícias
- Lexicon Pharmaceuticals’ Strategic Retrenchment Will Take Years To Show Results (LXRX)
- Lexicon (LXRX) Upgraded to Buy: Here's What You Should Know
- Jefferies raises Lexicon Pharmaceuticals stock price target to $0.85
- Lexicon Q2 2025 slides: Strategic pivot yields profit as pipeline advances
- Lexicon Pharmaceuticals (LXRX) Q2 Earnings and Revenues Top Estimates
- Lexicon earnings beat by $0.10, revenue topped estimates
- Supernus Pharmaceuticals (SUPN) Surpasses Q2 Earnings and Revenue Estimates
- Lexicon Pharmaceuticals regains Nasdaq compliance
- Lexicon Pharmaceuticals regains Nasdaq compliance for minimum bid price
- Lexicon Q1 2025 slides: EPS beat, revenue miss, strategic partnerships advance
- H.C. Wainwright reiterates buy rating on Lexicon Pharmaceuticals stock
- Lexicon to Present Data at the 85th Scientific Sessions of the American Diabetes Association (ADA)
- Novo signs $812 million weight-loss drug license deal with US biotech Deep Apple
- Novo signs $812 million weight-loss drug license deal with US biotech Deep Apple
- Lexicon Pharmaceuticals surges 67% following InvestingPro’s Fair Value signal
- Lexicon Pharmaceuticals at Jefferies Conference: Strategic Partnerships and Pipeline Progress
- Lexicon Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
- Lexicon at H.C. Wainwright Conference: Strategic Pipeline Developments
- SONATA-HCM Study Design Presented at Heart Failure 2025, the Annual Congress of the Heart Failure Association of the European Society of Cardiology
- Novo Nordisk Sheds 4% After Ousting CEO As Eli Lilly Rivalry Slams Stock Price
- Top 2 Health Care Stocks That May Crash This Month - Lexicon Pharmaceuticals (NASDAQ:LXRX), Amarin Corp (NASDAQ:AMRN)
- US Stocks Likely To Open Lower After 3-Day Fall: 'Equity Drawdown Probability Hasn't Peaked Yet,' Says Goldman Sachs Analyst - Babcock & Wilcox (NYSE:BW), AAR (NYSE:AIR)
- Lexicon's Drug Discovery Engine Validated By Novo's Obesity Drug Deal
- Nasdaq Down 100 Points; Federal Reserve's Favorite Inflation Gauge Increases More Than Expected - Lexicon Pharmaceuticals (NASDAQ:LXRX), DBV Technologies (NASDAQ:DBVT)
Faixa diária
1.09
1.15
Faixa anual
0.28
2.18
- Fechamento anterior
- 1.15
- Open
- 1.13
- Bid
- 1.10
- Ask
- 1.40
- Low
- 1.09
- High
- 1.15
- Volume
- 1.227 K
- Mudança diária
- -4.35%
- Mudança mensal
- 2.80%
- Mudança de 6 meses
- 197.30%
- Mudança anual
- -36.42%
31 agosto, domingo